Vastagbélrák: vizsgálatok itt: Franciaország
184 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Lyon, Marseille, Paris
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - No phaseTaking peopleAnalysis of Circulating Tumor Markers in Blood
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 992
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT04025541 - No phaseNot yet taking people in FranciaországMultidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 115
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
See details and how to joinNCT07404228 - 1/2. fázisTaking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Bordeaux, Caen, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Strasbourg, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Pierre-Bénite, Poitiers, Reims, Strasbourg, Villejuif
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - 1. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Where
- Poitiers, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- Pfizer
See details and how to joinNCT07318805 · EU 2025-524387-38-00 - 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Bordeaux, Caen Cedex 5, Lille Cedex, Lyon, Marseille, Paris, Saint-Priest-en-Jarez, Villejuif
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - 1. fázisTaking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Lyon, Saint-Herblain Cedex, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - 2. fázisTaking peopleRegorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
- Where
- Auxerre, Besançon, Chalon-sur-Saône, Colmar, Dijon, Lyon, Metz, Montbéliard, Montpellier, Nancy, Reims, Strasbourg
- Életkor
- 18 év and over
- People
- 174
- Run by
- Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT06425133 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Bordeaux, Brest, Lille, Montpellier, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Angers, Avignon, Caen Cedex 5, Limoges, Nice, Paris, Reims, Rouen, Toulouse Cedex 9, Vandoeuvre Les Nancy Cedex
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Paris, Saint-Herblain
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Avignon Cedex 9, Lille, Lyon, Montpellier Cedex 5, Nantes, Paris, Pessac, Poitiers, Villejuif
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Avignon Cedex 9, Pessac, Poitiers
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 1/2. fázisTaking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Bordeaux, Lyon, Marseille, Montpellier Cedex 5, Nice Cedex 2, Paris, Rouen Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Pierre-Bénite
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Marseille, Paris, Paris Cedex 15, Pessac, Poitiers, Reims Cedex, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - No phaseTaking peopleThe French Gut-colo
- Where
- Bobigny
- Életkor
- 50 év to 75 év
- People
- 2500
- Run by
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
See details and how to joinNCT06174233 - 1. fázisTaking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Bordeaux, Lyon, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - 2. fázisTaking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Lille, Lyon, Nantes, Paris, Poitiers
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00 - 3. fázisNot yet taking people in FranciaországStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Avignon Cedex 9, Brest, Caen Cedex 5, Dijon, La Chaussee St Victor, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Pierre-Bénite, Reims, Rennes, Saint-Herblain Cedex, Strasbourg, Tours
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Besancon Cedex, Bordeaux, Bordeaux Cedex, Dijon, Lyon, Montpellier Cedex 5, Paris, Rennes Cedex, Saint-Herblain Cedex, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleImpact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer
- Where
- Nîmes
- Életkor
- 70 év and over
- People
- 90
- Run by
- Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT05993923 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Besancon Cedex, Dijon, Lille, Limoges Cedex 1, Lorient, Marseille, Nantes, Paris, Pessac, Rouen, Saint-Herblain Cedex, Suresnes, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - 1/2. fázisTaking peopleA Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Where
- Bordeau, Marseille, Paris, Poitiers, Villejuif
- Életkor
- 18 év and over
- People
- 542 worldwide
- Run by
- Artios Pharma Ltd
See details and how to joinNCT04657068